Hepatic GH Receptor Signaling Directly Suppresses Hepatic Steatosis and De Novo Lipogenesis, Independent of Changes in Plasma IGF1 and Insulin

A reduction in GH, as well as IGF1, is associated with non-alcoholic fatty liver disease (NAFLD). However, the relative contribution of changes in circulating GH and IGF1, to hepatic triglyceride accumulation (steatosis), remains to be clearly defined. To study the direct actions of GH on hepatocyte...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Main Authors: Vazquez Borrego, Maria del Carmen, Moreno, Mercedes del Rio, Sarmento-Cabral, Andre, Mahmood, Mariyah, Subbaiah, Papasani V, Yakar, Shoshana, Cordoba-Chacon, Jose, Puchowicz, Michelle, Kineman, Rhonda D
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2021
Assuntos:
Adipose Tissue, Appetite, and Obesity
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089597/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.095
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares